Longitudinal follow up of Bone Density and Anthropometry of Children with Inflammatory Bowel Diseases

Yael Levy-Shraga 1,2 Anatoly Shenkar 1 Amit Assa 1,3 Yael Haberman 1,4 Dror Shouval 1,4 Avishay Lahad 1,4 Batia Weiss 1,4
1The Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel
2Pediatric Endcrinology and Diabetes Unit, The Edmond and Lily Safra Children's Hospital, Sheba Medical Center, Tel-Hashomer, Ramat-Gan, Israel
3Institute of Gastroenterology, Nutrition and Liver Disease, Schneider Children’s Medical Center, Petah-Tikva, Israel
4Division of Pediatric Gastroenterology and Nutrition, Edmond and Lily Safra Children's Hospital, Sheba Medical Center, Tel Hashomer, Ramat-Gan, Israel

Background: Pediatric inflammatory bowel disease (IBD) patients are prone to low bone mineral density (BMD) and increased risk for fractures. Our aim was to identify factors affecting BMD and to examine the longitudinal changes during follow up.

Methods: A retrospective longitudinal study conducted in 2 medical centers of BMD measurements of pediatric IBD patients by dual-energy X-ray absorptiometry (DXA). Corresponding data on anthropometry, disease activity, pharmacological and surgical treatment were collected.

Results: 152 patients (age at diagnosis 12.1±3.6, 73 males) were included, of them 111 had one and 41 patients had two DXA scans. Height-SDS, weight-SDS and BMI-SDS at the time of first DXA correlated with BMD (L1-4 z-score; R=0.4, 0.55, 0.44 respectively, p-2).

Conclusions: BMD and changes in BMD correlate with anthropometry and with corticosteroid use throughout follow up. The improvement in BMD is more pronounced in patients with initial L1-4 z-scores >-2 and in patients aged ≥18 years at the 2nd scan.









Powered by Eventact EMS